GSE152441,GSE152442 1 V 5 FOLIC ACID HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE152441,GSE152442 1 V 5 FOLIC ACID HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE152441,GSE152442 1 V 5 FOLIC ACID HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE152441,GSE152442 1 V 5 FOLIC ACID HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE152441,GSE152442 1 V 5 FOLIC ACID HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

mitochondrial rRNA methyltransferase 1

Gene

interleukin 3 receptor subunit alpha

Gene

zinc finger protein 311

Gene

tripartite motif containing 15

Gene

tripartite motif containing 10

Gene

SPATA31 subfamily C member 2

Gene

corin, serine peptidase

Gene

collapsin response mediator protein 1

Gene

BPI fold containing family B member 3

Gene

gamma-glutamyltransferase 5

  • Gene

    mitochondrial rRNA methyltransferase 1


  • Gene

    interleukin 3 receptor subunit alpha


  • Gene

    zinc finger protein 311


  • Gene

    tripartite motif containing 15


  • Gene

    tripartite motif containing 10


  • Gene

    SPATA31 subfamily C member 2


  • Gene

    corin, serine peptidase


  • Gene

    collapsin response mediator protein 1


  • Gene

    BPI fold containing family B member 3


  • Gene

    gamma-glutamyltransferase 5

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.